Prognosis

Prognosis

Tests that help determine the selection of therapy for tumours may also have additional prognostic value. For example, a BRAF mutation in metastatic CRC is associated with a very - poor prognosis. Commercially available multiple molecular marker tests may provide prognostic information (see Chapter 58 ). - Prognosis

Tests that help determine the selection of therapy for tumours may also have additional prognostic value. For example, a BRAF mutation in metastatic CRC is associated with a very - poor prognosis. Commercially available multiple molecular marker tests may provide prognostic information (see Chapter 58 ). - Prognosis

Tests that help determine the selection of therapy for tumours may also have additional prognostic value. For example, a BRAF mutation in metastatic CRC is associated with a very - poor prognosis. Commercially available multiple molecular marker tests may provide prognostic information (see Chapter 58 ). -